Pacific Biosciences of California presents advances in medical genetics and population genomics

Pacific Biosciences of California presents advances in medical genetics and population genomics
Pacific Biosciences unveils new genomics

Pacific Biosciences of California has released the latest edition of its Powered by PacBio quarterly review, offering a preview of new publications focused on population pangenomics, consolidation of clinical whole genome sequencing, and developments in medical genetics.

The company's recent research efforts aim to push the boundaries of genomic analysis and set new standards for population-scale studies and genetic diagnostics.

Pacific Biosciences recently drew strong engagement at ESHG2026, hosting packed sessions and community events in the final days of the conference, according to a previous report. The company has also expanded access to research by streaming its PRISM 2026 conference presentations on demand, as detailed in a recent update. These initiatives reflect Pacific Biosciences’ ongoing efforts to highlight genomic research and connect with the scientific community.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.